Clinical Nutrition Market Size to Exceed USD 19.77 Bn by 2032

The Clinical Nutrition Market, estimated at USD 13.15 Bn in 2025, is expected to exhibit a CAGR of 6% and reach USD 19.77 Bn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

Market players are engaged in increasing product launches, and this is expected to drive the global clinical nutrition market growth. For instance, in October 2025, OptiBiotix Health, a life

sciences company, had announced the in-license and launch of OptiXOS, its new xylooligosaccharide (XOS) prebiotic for the European and African markets. OptiXOS can significantly increase positive gut health microbes at low active doses, such as Bifidobacterium, as low as one gram. The ingredient also offers superior stability at high temperatures and a low pH.

Global Clinical Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems regarding the transportation of raw materials and manufacturing supplies from one place to another.

Factors such as investments in the research and development of novel nutritional products targeting COVID-19, as well as funding by various companies operating in the nutrition sector are expected to drive the global clinical nutrition market growth during the COVID-19 pandemic. Major developments and launches of medical nutritional products targeting health conditions such as cancer, diabetes, etc. and collaborations among the major players are highly contributing to the market growth. For instance, on September 14, 2025, Abbott, a global pharmaceutical company, announced the launch of its innovative childhood nutrition solution, the new PediaSure with arginine and natural vitamin K2 to support children's growth and development through proper nutrition.

Global Clinical Nutrition Market: Key Developments

In May 2025, Nestlé Health Science, a company operating in the nutritional science, agreed to acquire Puravida, a premium Brazil-based nutrition and health lifestyle brand. The acquisition will allow Nestlé Health Science to expand its consumer health portfolio in Brazil. Puravida is a well-known and fast-growing company that was created with the purpose of promoting health through nutrition. With its organic, natural, and plant-based foods, as well as cleanlabel and concentrated supplements, it is designed for consumers who take an active role in their wellbeing.

In June 2025, NextEvo Naturals, a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced the launch of its Ashwagandha Stress Reset Gummies on Amazon. Ashwagandha Stress Reset gummies are formulated with a proprietary, patented combination of both root and leaf to achieve maximum levels of all three bioactives including Withaferin A, Oligosaccharides, and Withanolides.

In April 2025, Fresenius Kabi Ltd, a global healthcare company, announced the launch of its UK and ROI Enteral Nutrition Product App. The Enteral Nutrition Product App makes it easier to access detailed product information and includes a quick comparison tool to compare nutritional values against reference nutrient intakes.

Browse 26 Market Data Tables and 29 Figures spread through 180 Pages and in-depth TOC on “Global Clinical Nutrition Market”- Forecast to 2032, Global Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition and Parenteral Nutrition), By Application (Cancer, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), By Age Group (Adult, Pediatric, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Link: https://www.coherentmarketinsights.com/market-insight/clinical-nutrition-market-980

Key Takeaways of the Global Clinical Nutrition Market:

• The global clinical nutrition market is expected to exhibit a CAGR of 6.0% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global clinical nutrition market.
• Among the application segment, the metabolic diseases segment is expected to hold a dominant position in the global clinical nutrition market over the forecast period. This is due to due to increasing product launches for the treatment of metabolic disorders by key players. For instance, on January 31, 2025, Nestlé Health Science, announced the launch of a new product, Nutren GlucoSmart, which is a nutritional solution, especially for people with diabetes.
• Among regions, North America is expected to be the dominant region in the global clinical nutrition market owing to increasing R&D activities regarding medical nutrition. For instance, in May 2025, Fresenius Kabi AG, a Germany-based global healthcare company, announced new data from the EuroPN Study. The EuroPN Study is a prospective study providing real-world evidence about nutrition and its associations with clinical outcomes in a mixed population of critically ill adult patients treated in European intensive care units (ICUs) for a minimum ICU length of stay of 5 days. The study showed that early medical nutrition therapy with moderate daily calorie and protein intakes is associated with improved clinical outcomes in critically ill patients. The study is a part of the ‘United for Clinical Nutrition’ initiative.
• The major players operating in the global clinical nutrition market are Abbott, Baxter, Fresenius SE & Co. KGaA, Persanfarma, Lonza, B. Braun SE, Nestlé, Danone S.A., Perrigo Company plc, BASF SE, Reckitt Benckiser Group PLC., and Otsuka Pharmaceutical Co., Ltd